Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985413133 | 9854131 | 33 | F | 20121126 | 20160920 | 20140129 | 20160923 | EXP | CA-ROCHE-1161332 | ROCHE | 72.05 | YR | F | Y | 99.00000 | KG | 20160923 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985413133 | 9854131 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B00069,B00060,B00963,B20131,B20071, | 125276 | 720 | MG | SOLUTION FOR INFUSION | |||||||
| 985413133 | 9854131 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B00069,B00060,B00963,B20131,B20071, | 125276 | 800 | MG | SOLUTION FOR INFUSION | |||||||
| 985413133 | 9854131 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | B00069,B00060,B00963,B20131,B20071, | 125276 | SOLUTION FOR INFUSION | |||||||||
| 985413133 | 9854131 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 985413133 | 9854131 | 5 | SS | ALENDRONATE | ALENDRONATE SODIUM | 1 | Unknown | D | 0 | ||||||||||
| 985413133 | 9854131 | 6 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 7 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 8 | C | PRO-HYDROXYQUINE | 2 | 0 | |||||||||||||
| 985413133 | 9854131 | 9 | C | IBUPROFENE | IBUPROFEN | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 10 | C | SULFASALAZINE. | SULFASALAZINE | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 11 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 12 | C | PAROXETINE. | PAROXETINE | 1 | 0 | ||||||||||||
| 985413133 | 9854131 | 13 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 0 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 985413133 | 9854131 | 1 | Rheumatoid arthritis |
| 985413133 | 9854131 | 4 | Blood cholesterol increased |
| 985413133 | 9854131 | 5 | Product used for unknown indication |
| 985413133 | 9854131 | 7 | Arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 985413133 | 9854131 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 985413133 | 9854131 | Agitation | |
| 985413133 | 9854131 | Arthralgia | |
| 985413133 | 9854131 | Arthropathy | |
| 985413133 | 9854131 | Back pain | |
| 985413133 | 9854131 | Blood cholesterol increased | |
| 985413133 | 9854131 | Blood pressure increased | |
| 985413133 | 9854131 | Blood pressure systolic increased | |
| 985413133 | 9854131 | Cholelithiasis | |
| 985413133 | 9854131 | Chromaturia | |
| 985413133 | 9854131 | Diarrhoea | |
| 985413133 | 9854131 | Drug effect decreased | |
| 985413133 | 9854131 | Electrocardiogram abnormal | |
| 985413133 | 9854131 | Fall | |
| 985413133 | 9854131 | Fungal infection | |
| 985413133 | 9854131 | Gastric disorder | |
| 985413133 | 9854131 | Haemorrhoids | |
| 985413133 | 9854131 | Headache | |
| 985413133 | 9854131 | Heart rate decreased | |
| 985413133 | 9854131 | Heart rate increased | |
| 985413133 | 9854131 | Hepatic steatosis | |
| 985413133 | 9854131 | Hyperhidrosis | |
| 985413133 | 9854131 | Hypotension | |
| 985413133 | 9854131 | Influenza | |
| 985413133 | 9854131 | Infusion related reaction | |
| 985413133 | 9854131 | Injection site bruising | |
| 985413133 | 9854131 | Joint swelling | |
| 985413133 | 9854131 | Ligament sprain | |
| 985413133 | 9854131 | Malaise | |
| 985413133 | 9854131 | Musculoskeletal pain | |
| 985413133 | 9854131 | Nasopharyngitis | |
| 985413133 | 9854131 | Osteoporosis | |
| 985413133 | 9854131 | Oxygen saturation decreased | |
| 985413133 | 9854131 | Pain | |
| 985413133 | 9854131 | Pain in extremity | |
| 985413133 | 9854131 | Peripheral swelling | |
| 985413133 | 9854131 | Poor dental condition | |
| 985413133 | 9854131 | Pruritus | |
| 985413133 | 9854131 | Pruritus generalised | |
| 985413133 | 9854131 | Rash | |
| 985413133 | 9854131 | Rash generalised | |
| 985413133 | 9854131 | Rheumatoid arthritis | |
| 985413133 | 9854131 | Weight decreased | |
| 985413133 | 9854131 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 985413133 | 9854131 | 1 | 20121025 | 0 | ||
| 985413133 | 9854131 | 2 | 20130214 | 0 | ||
| 985413133 | 9854131 | 3 | 20131022 | 0 | ||
| 985413133 | 9854131 | 5 | 2015 | 0 | ||
| 985413133 | 9854131 | 13 | 2013 | 0 |